Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/115941
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNicholls, S.en
dc.contributor.authorRay, K.en
dc.contributor.authorBallantyne, C.en
dc.contributor.authorBeacham, L.en
dc.contributor.authorMiller, D.en
dc.contributor.authorRuotolo, G.en
dc.contributor.authorNissen, S.en
dc.contributor.authorRiesmeyer, J.en
dc.date.issued2017en
dc.identifier.citationAtherosclerosis, 2017; 261:12-18en
dc.identifier.issn0021-9150en
dc.identifier.issn1879-1484en
dc.identifier.urihttp://hdl.handle.net/2440/115941-
dc.description.abstractAbstract not availableen
dc.description.statementofresponsibilityStephen J. Nicholls, Kausik K. Ray, Christie M. Ballantyne, Lauren A. Beacham, Debra L. Miller, Giacomo Ruotolo, Steven E. Nissen, Jeffrey S. Riesmeyer (for theACCENTUATE Investigators)en
dc.language.isoenen
dc.publisherElsevieren
dc.rights© 2017 Elsevier B.V. All rights reserved.en
dc.subjectCETP; clinical trials; lipids; cardiovascular diseaseen
dc.titleComparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: the ACCENTUATE trialen
dc.typeJournal articleen
dc.identifier.rmid0030068719en
dc.identifier.doi10.1016/j.atherosclerosis.2017.04.008en
dc.identifier.pubid348652-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS14en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidNicholls, S. [0000-0002-9668-4368]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.